Birgit Jaitner

European Bioanalysis Forum recommendation on method establishment and bioanalysis of biomarkers in support of drug development.

S. Bates, A. Versteilen, P. Timmerman, 2012, Bioanalysis.

EBF recommendation on practical management of critical reagents for antidrug antibody ligand-binding assays.

P. Timmerman, Birgit Jaitner, Susanne Pihl, 2019, Bioanalysis.

Colony-Stimulating Factor-1 Antibody Lacnotuzumab in a Phase 1 Healthy Volunteer Study and Mechanistic Investigation of Safety Outcomes

P. Couttet, F. Pognan, R. Roubenoff, 2019, The Journal of Pharmacology and Experimental Therapeutics.

Pharmacokinetics and Pharmacodynamics of Tocilizumab for the Management of Cytokine Release Syndrome (CRS) in Pediatric and Young Adult Patients with Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL) Treated with CAR T-Cell Therapy, CTL019

S. Rives, S. Grupp, Birgit Jaitner, 2017 .

2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3--LBA, biomarkers and immunogenicity).

Renuka Pillutla, Viswanath Devanarayan, An Song, 2015, Bioanalysis.

EBF recommendation on practical management of critical reagents for PK ligand-binding assays.

Philip Timmerman, Joanne Goodman, Marianne Scheel Fjording, 2018, Bioanalysis.